A refined concept: a-synuclein dysregulation disease

Neurochemistry International 119 (2018) 84e96

Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum

Neurochemical Research https://doi.org/10.1007/s11064-018-2673-x

Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum

Neurochemical Research https://doi.org/10.1007/s11064-018-2673-x

Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum

Neurochemical Research https://doi.org/10.1007/s11064-018-2673-x

ER–mitochondria signaling in Parkinson’s disease

Cell Death and Disease (2018) 9:337

ER–mitochondria signaling in Parkinson’s disease

Cell Death and Disease (2018) 9:337

Aging and Parkinson's Disease: Inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis

Free Radical Biology and Medicine 115 (2018) 80–91

Natural Compounds for the Management of Parkinson’s Disease and Attention-Deficit/Hyperactivity Disorder

BioMed Research International Volume 2018

Mucuna pruriens in Parkinson disease A double-blind, randomized, controlled, crossover study

Neurology® 2017;89:1–7
Mucuna pruriens in Parkinson’s disease: a double blind clinical and pharmacological study

J. Neurol. Neurosurg. Psychiatry 2004;75;1672-1677

Mucuna pruriens in Parkinson’s disease: a double blind clinical and pharmacological study

J. Neurol. Neurosurg. Psychiatry 2004;75;1672-1677

Mucuna and Parkinson’s Disease: Treatment with Natural Levodopa

http://dx.doi.org/10.5772/intechopen.74062
The potential role of herbal products in the treatment of Parkinson’s disease

Clin Ter 2018; 169 (1):e23-33. doi: 10.7417/T.2018.2050

The potential role of herbal products in the treatment of Parkinson’s disease

Clin Ter 2018; 169 (1):e23-33. doi: 10.7417/T.2018.2050

Anti-Parkinson Potential of Silymarin :Mechanistic Insight and Therapeutic Standing

Front. Pharmacol. 9:422. doi: 10.3389/fphar.2018.00422

Preclinical and Potential Applications of Common Western Herbal Supplements as Complementary Treatment in Parkinson's Disease

Journal of Dietary Supplements ISSN: 1939-0211 (Print) 1939-022X

Nutraceuticals in Parkinson’s Disease

Neuromol Med (2016) 18:306–321

Important medicinal herbs in Parkinson’s disease pharmacotherapy

Biomedicine & Pharmacotherapy 92 (2017) 856–863

Natural Products Combating Neurodegeneration: Parkinson’s Disease

Current Drug Metabolism, 2016, 17, 000-000

Potential Therapeutic Properties of Green Tea Polyphenols in Parkinson’s Disease

Drugs Aging 2003; 20 (10): 711-721

Neuroprotective Effects of Garlic in Model Systems of Neurodegenerative Diseases

DOI: http://dx.doi.org/10.1016/B978-0-12-811959-4.00016-X
A New Hope for a Devastating Disease: Hydrogen Sulfide in Parkinson’s Disease

Mol Neurobiol DOI 10.1007/s12035-017-0617-0

The physiological role of hydrogen sulfide and beyond

Nitric Oxide 41 (2014) 4–10

Natural Compounds for the Management of Parkinson’s Disease and Attention-Deficit/Hyperactivity Disorder

BioMed Research International Volume 2018

Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota

Signal Transduction and Targeted Therapy (2021) 6:77

Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota

Signal Transduction and Targeted Therapy (2021) 6:77

A Double-Blind, Randomized, Controlled Trial of Lovastatin in Early-Stage Parkinson’s Disease

Lovastatin 80 mg/day Movement Disorders, 2021

Efficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson’s disease: a preliminary finding

50 mg of 5-HTP European Journal of Neurology 2020, 27: 779–786

Efficacy and safety of 5-hydroxytryptophan on depression and apathy in Parkinson’s disease: a preliminary finding

50 mg of 5-HTP European Journal of Neurology 2020, 27: 779–786

Preclinical and Potential Applications of Common Western Herbal Supplements as Complementary Treatment in Parkinson's Disease

Journal of Dietary Supplements ISSN: 1939-0211 (Print) 1939-022X

Nutraceuticals in Parkinson’s Disease

Neuromol Med (2016) 18:306–321

Nutraceuticals in Parkinson’s Disease

Neuromol Med (2016) 18:306–321

Nutraceuticals in Parkinson’s Disease

Neuromol Med (2016) 18:306–321

Nutraceuticals in Parkinson’s Disease

Neuromol Med (2016) 18:306–321

Nutraceuticals in Parkinson’s Disease

Neuromol Med (2016) 18:306–321

Nutraceuticals in Parkinson’s Disease

Neuromol Med (2016) 18:306–321

Nutraceuticals in Parkinson’s Disease

Neuromol Med (2016) 18:306–321

Important medicinal herbs in Parkinson’s disease pharmacotherapy

Biomedicine & Pharmacotherapy 92 (2017) 856–863

Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits

Neurochemistry International 89 (2015) 181e190

Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits

Neurochemistry International 89 (2015) 181e190

The Centrality of Mitochondria in the Pathogenesis and Treatment of Parkinson’s Disease

CNS Neuroscience & Therapeutics 20 (2014) 591–602

Green Tea Consumption Reduces Oxidative Stress in Parkinson’s Disease Patients

Journal of Behavioral and Brain Science, 2015, 5, 194-202

Green Tea Consumption Reduces Oxidative Stress in Parkinson’s Disease Patients

Journal of Behavioral and Brain Science, 2015, 5, 194-202

Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits

Neurochemistry International 89 (2015) 181e190

Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits

Neurochemistry International 89 (2015) 181e190

Parkinson’s Disease: Mitochondrial Molecular Pathology, Inflammation, Statins, and Therapeutic Neuroprotective Nutrition

Nutrition in Clinical Practice Volume 25 Number 4 August 2010 371-389

Parkinson’s Disease: Mitochondrial Molecular Pathology, Inflammation, Statins, and Therapeutic Neuroprotective Nutrition

Nutrition in Clinical Practice Volume 25 Number 4 August 2010 371-389

Parkinson
• Neuroinflamação.
• Neuroproteção.
• Estresse oxidativo.
• Quelação de metais tóxicos e de transição.
• Fonte de levodopa – mucuna.
• Polifenóis.
• Ainda muito a pesquisar.
OBRIGADO